Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation
Condition(s):Tachycardia, Ventricular; Catheter AblationLast Updated:November 14, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Tachycardia, Ventricular; Catheter AblationLast Updated:November 14, 2022Terminated
Condition(s):Antiarrhythmic Drug Adverse ReactionLast Updated:February 22, 2024Not yet recruiting
Condition(s):Antiarrhythmic ToxicityLast Updated:May 6, 2021Unknown status
Condition(s):Atrial FibrillationLast Updated:October 18, 2023Active, not recruiting
Condition(s):Atrial FibrillationLast Updated:July 11, 2022Completed
Condition(s):Atrial Fibrillation; Atrial Fibrillation New OnsetLast Updated:August 11, 2021Completed
Condition(s):Heart Disease Structural Disorder; Ventricular Tachycardia; Cardiomyopathy, Dilated; Sarcoidosis; Cardiomyopathy, Hypertrophic; Cardiomyopathy Ischemic; Cardiomyopathy, Familial; Arrhythmogenic Right Ventricular Cardiomyopathy 1; Arrhythmogenic Left Ventricular CardiomyopathyLast Updated:September 1, 2022Recruiting
Condition(s):Atrial FibrillationLast Updated:January 31, 2020Completed
Condition(s):Mild Cognitive Impairment; Persistent Atrial FibrillationLast Updated:May 26, 2023Recruiting
Condition(s):Persistent Atrial FibrillationLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.